The pcDNA1 expression constructs encoding MBP-tagged forms of truncated or full-length forms of wild-type and D600A RAG1 and wild-type RAG2 have been described previously (Bergeron et al, 2006) . Constructs encoding the murine equivalent of the C328Y RAG1 mutant associated with Omenn syndrome (mC325Y) or an mC328Y RAG1 mutant were generated by inside out PCR using primers C325YFor
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Protein expression and purification
The pcDNA1 expression constructs encoding MBP-tagged forms of truncated or full-length forms of wild-type and D600A RAG1 and wild-type RAG2 have been described previously (Bergeron et al, 2006) . Constructs encoding the murine equivalent of the C328Y RAG1 mutant associated with Omenn syndrome (mC325Y) or an mC328Y RAG1 mutant were generated by inside out PCR using primers C325YFor
(5'AGTCATGGGATCCTATTATCCCTCTTGCCGATATCCGTGCTTC-3') and C325YRev
(5'-GATATCGGCAAGAGGGATAATAGGATCCCATGACTTTGAGACA-3') or C328YFor (5'-AGCTATTGTCCCTCTTACCGGTATCCGTGCTTCCCTACTGAC-3') and C328YRev (5'-GGAGCACGGATACCGGTAAGAGGGACAATAGCTGCCCATGAC-3'), respectively, using a TOPO-TA plasmid encoding residues 151-1040 of RAG1 or pcFLMR1 as templates for C325Y and C328Y mutants respectively. Tyrosine replacement codons are underlined and diagnostic BamHI and AgeI restriction sites are italicized (created by introducing silent mutations). Samples were subjected to initial denaturation at 94 °C, followed by 25 cycles of amplification (94 °C for 4 min, 60 °C for 30 sec and 72 °C for 10 min) or (94 °C for 5 min, 60 °C for 30 sec and 72 °C for 16 min) respectively for the C325Y and C328Y mutants, with a final extension at 72 °C for 30 min. The PCR products were gel purified and transformed into TOP10 bacterial cells. Recombinant plasmids were selected by the presence of a diagnostic BamHI and AgeI restriction site for the C325Y and C328Y mutants, respectively. The DNA sequence was verified in this region and subcloned back into the parent pcFLMR1 vector using BsmB1 and EcoRV sites for the C325Y mutant and BsmBI and SphI for the C328Y mutant, respectively.
MBP-RAG1 and MBP-RAG2 fusion proteins were co-expressed in various combinations (cMR1/cMR2, cMR1/FLMR2, and FLMR1/cMR2, respectively, using either wild-type or mutant forms of RAG1; see Fig. 1 , and Fig. S2 ) in HEK293 cells and purified by amylose affinity chromatography under mild conditions as previously described (Raval et al, 2008) . The panel of RAG1 truncation mutants shown in Fig. 2C has been described previously (Raval et al, 2008) . The RAG proteins used for in vitro ubiquitylation assays were purified using the same procedure as Raval et al (2008) , except that the HEPES buffer was substituted with the IP buffer used in pull-down assays, as these conditions were found to improve protein recovery and increase the consistency of ubiquitylation reactions (data not shown).
To express full-length VprBP in mammalian cells, an EcoR1-NotI fragment was removed from pTet-VprBP-FH encoding full-length VprBP with a C-terminal FLAG epitope and polyhistidine tag (Zhang et al, 2001) , and subcloned into the mammalian expression construct pcDNA1 (Invitrogen).
Mammalian expression constructs encoding truncated forms of VprBP with an N-terminal triple-epitope (tagged with S-protein, FLAG, and streptavidin-binding peptide) were kindly provided by J. Chen (Huang & Chen, 2008) . These constructs were transfected individually into HEK 293 cells (ten 150 mm plates) using polyethyleneimine (PEI) as previously described (Bergeron et al, 2006) . To purify full-length or truncated forms of VprBP, cells were harvested from five plates at 48h post-transfection and resuspended in 4.0 mL lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 1% Triton X100, 1 mM EDTA, protease inhibitors [1 µM pepstatin A, 2 µM leupeptin and 100 µM PMSF]), mixed gently on an orbital rocker (4° C, 15 min) and the lysate clarified by centrifugation (22,000 rpm using a Beckman SW55Ti rotor for 30 min at 4° C). Pooled supernatants were incubated with sepharose beads conjugated with anti-FLAG antibody (Sigma, 0.5 mL beads) for 2 hr at 4° C and loaded on to a Poly-Prep Chromatography Column (BioRAD), washed with 3 column volumes of lysis buffer, followed by 5 column volumes of buffer R (25 mM HEPES, 150 mM NaCl, 1mM DTT, 10 mM MgCl 2 and 10% glycerol). The proteins were eluted in buffer R containing 100 µg/ml FLAG peptide, snap frozen on liquid nitrogen, and stored at -80° C.
VprBP, DDB1, Cul4, and Roc1 were coexpressed in various combinations and purified from insect cells using a baculovirus expression system (baculovirus stocks expressing DDB1, Cul4, ROC1, or VprBP were kind gifts of Y. Xiong (unpublished). In this expression system, DDB1 and Cul4 are tagged at the N-terminus with GST, VprBP is tagged with C-terminal FLAG epitope, and Roc1 is untagged. Insect SF9 cells were maintained at 27 °C in SF-900 II medium (Invitrogen) containing 5% FBS. Four 75 mL flasks were co-infected with the various baculovirus stocks (1.0 mL of each stock), harvested at 48h post-infection, and stored at -80° C until use. Cell lysates were prepared and clarified as described for the purification of VprBP from mammalian cells. Glutathione-conjugated agarose beads (Sigma-Aldrich) were prepared by pre-swelling 70 mg beads in water for 1h, followed by sequential washes in water (3 times; 6mL/wash) and then lysis buffer (2 times; 6 mL/wash). The beads were incubated with the pooled supernatant under gentle rotation (4° C, 1 hr) and then loaded into a Poly-Prep column. The resin was washed three times with lysis buffer (2 mL/wash), followed by five washes with lysis buffer lacking Triton X100, and finally eluted with the same buffer containing 10 mM reduced glutathione. Immunoblotting Protein samples were separated by SDS-polyacrylamide gel electrophoresis on either a 7% polyacrylamide gel or a BIO RAD MiniProtein TGX gel (7.5% or 4-20% polyacrylamide) and transferred to PVDF membrane (Immobilon P; Millipore, Billerica, MA) in transfer buffer (12.5 mM Tris, 96 mM glycine, 15% methanol) using a Trans-Blot Cell (Bio-Rad, Hercules, CA) running at 45 volts overnight at 4 °C. For the blocking step, the membrane was incubated in TBST buffer (0.1 M Tris-HCl [pH 7.6], 0.9% NaCl and 0.1% Tween-20) containing 5% non-fat dry milk for 1 hour at room temperature. Antibody was added according to manufacturer's recommendation in 10 ml TBST buffer and incubated either for 15 hrs at 4º C or 1 hr at 25ºC. After washing with TBST, membranes were developed using either ECF (A) Wild-type (WT), C325Y, or C328Y core or full-length MBP-tagged RAG1 (cMR1 or FLMR1, respectively) was co-expressed with cMR2 in 293 cells and purified by amylose affinity chromatography. Whole cell lysates prepared from transfected cells were probed by IB using anti-MBP antibodies (top) and purified proteins were visualized after SDS-PAGE by staining with SYPRO orange (bottom). Note the greater abundance of a truncated form of MBP-tagged RAG1, denoted by (*), in cells expressing mC325Y and mC328Y RAG1. (B) RAG protein preparations in (A) were incubated in binding reactions containing a radiolabeled 12RSS (lanes 1-9) or 23RSS (lanes 10-18) in the absence or presence of HMGB1 and cold 12-RSS or 23-RSS partner as indicated, and protein-DNA complex formation was visualized by EMSA. The various RAG-RSS complexes are designated following the nomenclature of Raval et al. (Raval et al, 2008) . (C) Strategy to detect signal joint (SJ) and coding joint (CJ) formation on the plasmid V(D)J recombination substrate pJH299 after V(D)J recombination in cells by PCR using primers SJ1 and SJ2, or CJ1 and CJ2, respectively. (D) Plasmid pJH299 DNA recovered from 293 cells transfected with pcDNA1 expression constructs encoding wild-type (WT) or catalytically inactive (D600A; negative control) core or full-length MBP-RAG1 (cMR1 or FLMR1, respectively) and core MBP-RAG2 (cMR2) was subjected to PCR to detect signal joints and coding joints. PCR products were visualized on an agarose gel stained with ethidium bromide. A fragment of the chloramphenicol acetyltransferase (CAT) gene was amplified as a loading control. (E) Strategy to detect signal ends created after RAG-mediated RSS cleavage in cells using ligation-mediated PCR. Cleavage at either RSS yields a signal end break (SEB) that can be ligated to linker DNA and amplified by PCR using a linker primer (LP) and sequence 3' of the 23-RSS (23P). (F) Plasmid DNA isolated from cells transfected as indicated in panel D was subjected to LM-PCR and the products were visualized as described therein. Products corresponding to SEBs introduced at the 12RSS or 23RSS are identified at left. Purified KPNA1 (A), histone H3.1 (B), histone H3.3 (C), or Ku70/Ku80 (D) was incubated in an in vitro ubiquitylation reaction containing purified WT, mC325Y, or mC328Y FLMR1/cMR2 or WT cMR1/cMR2, myc-Ub, and E1 and E2 enzymes in the combinations indicated above the gels. Reactions were subsequently probed by IB using the indicated antibodies. (E) Samples from a complete preparative in vitro ubiquitylation reaction containing FLMR1/cMR2, myc-Ub, and E1 and E2 enzymes (no substrate protein added) were removed at the indicated times and analyzed by IB to detect de novo ubiquitylation. Control reactions lacking FLMR1/cMR2 or E1 were analyzed at early and late time points in parallel. Cells prepared from bone marrow (BM), spleen (SPL), or thymus (THY) of mice with indicated genotypes (described in Fig. 4 ) and identified by the gating parameters shown below each row were analyzed for the expression of CD19 and CD24 (A), or CD4 and CD8 (B-C). Developmental subsets specified by the staining pattern are indicated at right with corresponding gates. TTTATTACTACGGT********* GGG ********GCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -79.6 DFL16.1 TTTATTACTACGGTAGTAGCTAC GTG ***********ATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -110.11 DFL16.1 TTTATTACTACGGTAGTAGCT** CTTC ****************CTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -56.9 DFL16.1 TTTATTACTACGGTAGTAGCTAC GTAA ATTACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -110.2 DFL16.1 (2) TTTATTACTACGGTAGTAGCTAC GTGGG *************GGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.12,79.2 DFL16.1 TTTATTACTACGGTAGTAG**** CCCTT ATTACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -32.10 DFL16.1 TTTATTACTACGGTAGTAGCTAC GTATC **TACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.23 DFL16.1 TTTATTACTACGGTAGTAGCTAC GTGGG *************GGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -110.22 DFL16.1 TTTATTACTACGGTAGTAG**** GAATT **********ATGGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -110.25 DFL16.1 TTTATTACTACGGTAG******* AGGGGG ********GCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -32.2 DFL16.1 TTTATTACTACGGTAG******* AGAGGGT ****CTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.24 DFL16.1/16.1j TTT******************** CCCACTC *******TGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -79.4 DFL16.1j TTTATTACTACGA********** GGG ****CTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.29 DSP2.x (Germline) CCTACTATAGTAACTAC ATTACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -JH4 Germline DSP2.x CCTACTATAGTAACTAC G ******ATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.16 DSP2.x CCTACTATAGTAAC*** CT *TTACTATGCTgTGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.5 DSP2.x (2) CCTACTATAGTAA**** AGGG ********GCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.18,51.25 DSP2.x CCTACTATAGTAACT** TGGG *******TGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -51.22 DSP2.x CCTACTATAG******* CCCT ********GCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -32.9 DSP2.x/2.6/2.7 CCTACT*********** CCGAATGAT ATTACTATGCTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -56. TTTAT****************** CCGGCG *********************GGGGTCAAGGAACCTCAGTCACCGTCTCCTCA -28.13 
DSP2.2 (Germline)

